2001
Health care utilization among young adult injection drug users in Harlem, New York
Cronquist A, Edwards V, Galea S, Latka M, Vlahov D. Health care utilization among young adult injection drug users in Harlem, New York. Journal Of Substance Abuse 2001, 13: 17-27. PMID: 11547618, DOI: 10.1016/s0899-3289(01)00073-6.Peer-Reviewed Original ResearchConceptsYoung adult injection drug usersAdult injection drug usersInjection drug usersNeedle exchange programsHealth care utilizationCare utilizationHealth careDrug treatmentDrug usersHealth insuranceMedical careYoung injection drug usersCross-sectional studyHealth insurance coverageNEP usersUse of servicesDrug useHealth servicesAge 18Logistic regressionHealth conditionsCareInsurance coverageMonthsTreatmentHighly Active Antiretroviral Therapy Associated with Improved Anemia Among HIV-Infected Women
Semba R, Shah N, Klein R, Mayer K, Schuman P, Gardner L, Vlahov D. Highly Active Antiretroviral Therapy Associated with Improved Anemia Among HIV-Infected Women. AIDS Patient Care And STDs 2001, 15: 473-480. PMID: 11587633, DOI: 10.1089/108729101753145466.Peer-Reviewed Original ResearchConceptsPrevalence of anemiaAntiretroviral therapyHuman immunodeficiency virus (HIV) infectionActive antiretroviral therapyCombination antiretroviral therapyImmunodeficiency virus infectionHIV-positive womenYears of treatmentIncrease of hemoglobinImproved anemiaMulticenter cohortVirus infectionHAARTAnemiaHIVWomenTherapyLinear regression modelsPrevalenceTreatmentBaselineHemoglobinRegression modelsSignificant changesMonotherapy
2000
Consideration of a North American heroin-assisted clinical trial for the treatment of opiate-dependent individuals
Kuo I, Fischer B, Vlahov D. Consideration of a North American heroin-assisted clinical trial for the treatment of opiate-dependent individuals. International Journal Of Drug Policy 2000, 11: 357-370. PMID: 10967518, DOI: 10.1016/s0955-3959(00)00057-8.Peer-Reviewed Original ResearchMethadone treatmentMajor public health problemOpiate addictsAdditional treatment strategiesHeroin-assisted treatmentPrincipal treatment modalityPublic health problemOpiate-dependent individualsSubstance abuse treatmentTreatment modalitiesClinical trialsTreatment outcomesTreatment strategiesSide effectsEconomic burdenHealth problemsInjectable opiatesTreatment programAbuse treatmentTreatment participationEffective interventionsTreatmentPositive resultsAddictsRecent studiesUse of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART
Carrieri M, Vlahov D, Dellamonica P, Gallais H, Lepeu G, Spire B, Obadia Y, Group T. Use of buprenorphine in HIV-infected injection drug users: negligible impact on virologic response to HAART. Drug And Alcohol Dependence 2000, 60: 51-54. PMID: 10821989, DOI: 10.1016/s0376-8716(00)80007-1.Peer-Reviewed Original ResearchConceptsEfficacy of HAARTDrug usersBuprenorphine substitution treatmentViral load trendsActive antiretroviral therapyFrench cohort studyHIV viral loadUse of buprenorphineInjection drug usersVirologic responseAntiretroviral therapyCohort studyBuprenorphine treatmentTreatment initiationViral loadMaintenance treatmentPotential confoundersHAARTSubstitution treatmentBuprenorphineHIVIndividual treatmentPatientsTreatmentLinear regression models
1999
Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group.
Carrieri M, Moatti J, Vlahov D, Obadia Y, Reynaud-Maurupt C, Chesney M. Access to antiretroviral treatment among French HIV infected injection drug users: the influence of continued drug use. MANIF 2000 Study Group. Journal Of Epidemiology & Community Health 1999, 53: 4. PMID: 10326045, PMCID: PMC1756774, DOI: 10.1136/jech.53.1.4.Peer-Reviewed Original ResearchConceptsActive injection drug usersInjection drug usersAntiretroviral treatmentFrench HIVDrug useDrug usersFormer injection drug usersDetailed clinical historyPast drug useEx-IDUsIDU patientsClinical stageClinical historyAIDS careHospital careAIDS specialistsCell countNew treatmentsRisk behaviorsHospital departmentsLogistic regressionHIVPatientsPhysiciansTreatment
1994
Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users
Schütz C, Rapiti E, Vlahov D, Anthony J. Suspected determinants of enrollment into detoxification and methadone maintenance treatment among injecting drug users. Drug And Alcohol Dependence 1994, 36: 129-138. PMID: 7851280, DOI: 10.1016/0376-8716(94)90095-7.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAmphetamineBaltimoreCocaineCross-Sectional StudiesFemaleFollow-Up StudiesHeroin DependenceHIV InfectionsHumansMaleMethadoneMiddle AgedOpioid-Related DisordersPatient Acceptance of Health CarePatient AdmissionProspective StudiesRisk FactorsSocial EnvironmentSubstance Abuse, IntravenousSubstance-Related DisordersUrban PopulationConceptsMethadone maintenance treatmentMethadone maintenance programDrug usersIndependent predictorsMaintenance treatmentMultiple logistic regression analysisLogistic regression analysisProspective study designTime of recruitmentActive drug usersCross-sectional investigationIDU participantsMethadone maintenanceDrug overdoseNext followDetoxification programCommunity outreach effortsTreatment settingsPrior treatmentDrug useDetoxification treatmentStudy designUntreated drug usersTreatmentRegression analysis
1992
HIV INFECTION AND AIDS AMONG U.S. PRISON INMATES
Behrendt C, Vlahov D, Clark J, Kendig N. HIV INFECTION AND AIDS AMONG U.S. PRISON INMATES. Journal Of Crime And Justice 1992, 15: 173-186. DOI: 10.1080/0735648x.1992.9721458.Peer-Reviewed Original ResearchHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionIntravenous drug useVoluntary HIV testingOnset of AIDSCause of deathRisk reduction programsHIV infectionHIV testingHIV-positiveImmunodeficiency syndromeHigh prevalenceVirus infectionHigh riskGeneral populationElevated incidenceDrug usePrison inmatesTesting treatmentsHealth careAIDSState prison systemInfectionTreatmentMore researchCorrelates of human immunodeficiency virus infection in intravenous drug users: are treatment‐program samples misleading?
ALCABES P, VLAHOV D, ANTHONY J. Correlates of human immunodeficiency virus infection in intravenous drug users: are treatment‐program samples misleading? Addiction 1992, 87: 47-54. PMID: 1311973, DOI: 10.1111/j.1360-0443.1992.tb01899.x.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHIV-1 seropositivityDrug usersTreatment programHuman immunodeficiency virus (HIV) infectionHIV-1 seroprevalenceImmunodeficiency virus infectionHuman immunodeficiency virusDrug use characteristicsCommunity-based sampleDrug use behaviorsImmunodeficiency virusPossible selection biasRisk factorsVirus infectionType 1SeropositivityTreatmentCommunity service agenciesConfidential interviewsSelection biasSubjectsUse behaviorsExtensive distributionCorrelatesHIV-1 infection in the correctional setting.
Vlahov D. HIV-1 infection in the correctional setting. NIDA Research Monograph 1992, 118: 51-61. PMID: 1620226.Peer-Reviewed Original Research